PATENT CLAIM ANALYSIS

Application Number: 15888736
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-01
Patent Classification: ["514", "235200"]

Abstract:
Described herein are compounds that modulate the activity of TNAP. In some embodiments, the compounds described herein inhibit TNAP. In certain embodiments, the compounds described herein are useful in the treatment of conditions associated with hyper-mineralization.

Claim (Index 35):
The method of  claim 1 , wherein the vascular calcification is associated with chronic renal disease (chronic renal insufficiency), end-stage renal disease, or pre- or post-dialysis or uremia.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 88.0
- Lexical Diversity: 1.64
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14379475', '15546165', '12291756', '15319329', '15799771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8277796397904152
- 35 USC 102 Novelty (BERT): 0.5557896802282507
- Combined Prediction Score: 0.8005806438341988
- Mean Citation Score: 425.3989360000001
- Max Citation Score: 484.9471
- Similarity Product: 288.50376495735645

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test